amikacin has been researched along with Respiratory Distress Syndrome, Newborn in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boukadida, J; Monastiri, K; Salem, N; Seket, B; Snoussi, N; Taher, NB | 1 |
| Assael, BM; Cavanna, G; Parini, R; Rusconi, F | 1 |
2 other study(ies) available for amikacin and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
[Initial antibiotic therapy in maternal-fetal infections which include ampicillin even in countries where listeriosis is an incidental disease].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clinical Protocols; Fatal Outcome; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Listeriosis; Male; Penicillins; Respiratory Distress Syndrome, Newborn | 2002 |
Monitoring of amikacin in the neonate.
Topics: Age Factors; Amikacin; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Kanamycin; Respiratory Distress Syndrome, Newborn; Time Factors | 1983 |